SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966) (RGNT) — Sep 8, 2025

REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966)
Date: Sept. 8, 2025 · CIK: 0001912966 · Accession: 0001213900-25-085647

AI Filing Summary & Sentiment

File numbers found in text: 333-285692

Date
September 8, 2025
Author
Not clearly detected
Form
CORRESP
Company
REGENTIS BIOMATERIALS LTD. (RGNT) (CIK 0001912966)

Letter

Regentis Biomaterials Ltd.

60 Medinat Hyahudim

Hertzliya, Israel 4676652

September 8, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

RE: Regentis Biomaterials Ltd. (CIK 0001912966)

Registration Statement No. 333-285692 on Form F-1 (the “Registration Statement”)

Ladies and Gentlemen:

Regentis Biomaterials Ltd. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on September 10, 2025 at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling David Huberman at 312.364.1633. The Company hereby authorizes Mr. Huberman to orally modify or withdraw this request for acceleration.

Very truly yours,
REGENTIS BIOMATERIALS LTD.

Show Raw Text
CORRESP
1
filename1.htm

Regentis Biomaterials Ltd.

60 Medinat Hyahudim

Hertzliya, Israel 4676652

September 8, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    Regentis Biomaterials Ltd. (CIK 0001912966)

    Registration Statement No. 333-285692 on Form F-1 (the “Registration Statement”)

Ladies and Gentlemen:

Regentis Biomaterials Ltd.
(the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement
pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective
on September 10, 2025 at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.

The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A.,
by calling David Huberman at 312.364.1633. The Company hereby authorizes Mr. Huberman to orally modify or withdraw this request for acceleration.

    Very truly yours,

    REGENTIS BIOMATERIALS LTD.

    By:
    /s/ Dr. Eli Hazum

    Dr. Eli Hazum

Chief Executive Officer